CytoCell DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe, Model Number LPU004-A. analyte sp...

FDA Device Recall #Z-2134-2021 — Class II — May 17, 2021

Recall Summary

Recall Number Z-2134-2021
Classification Class II — Moderate risk
Date Initiated May 17, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cytocell Ltd.
Location Cambridge, N/A
Product Type Devices
Quantity 50

Product Description

CytoCell DiGeorge/VCFS TUPLE1 Region and 22q13.3 Region Probe, Model Number LPU004-A. analyte specific reagent for in vitro diagnostics

Reason for Recall

The device may show unexpected locus specific signals in addition to those at 22q. Users may observe faint additional locus specific signals at 20p12/13.

Distribution Pattern

Distribution to US states of CA, IL, MO, NY, PA, TX, and UT, and Canada.

Lot / Code Information

Lot Numbers: 071399 072985

Other Recalls from Cytocell Ltd.

Recall # Classification Product Date
Z-2210-2023 Class II RET Distal Probe. Used in Fluorescence in situ ... May 24, 2023
Z-2209-2023 Class II RET Proximal Probe. Used in Fluorescence in sit... May 24, 2023
Z-0353-2023 Class II CytoCell BCL11B Proximal in FITC Spectrum-LDT f... Oct 27, 2022
Z-0341-2023 Class II CytoCell BCL11B Distal in Texas Red Spectrum- A... Oct 27, 2022
Z-0824-2022 Class III Cytocell 8 Square Template Slides (Glass)- micr... Feb 14, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.